| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-12 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |